Crinetics Pharmaceuticals Sees Stock Price Target Raised by Two Firms
Crinetics Pharmaceuticals has experienced a significant boost in investor confidence as both Morgan Stanley and Jones Trading raised their stock price targets. Morgan Stanley increased its target from $65 to $77, while Jones Trading set a new target at $85. These adjustments reflect a positive outlook for Crinetics in the biotech sector, potentially attracting more investors.
Crinetics Pharmaceuticals Sees Stock Price Target Raised by Two Firms
Crinetics Pharmaceuticals has experienced a significant boost in investor confidence as both Morgan Stanley and Jones Trading raised their stock price targets. Morgan Stanley increased its target from $65 to $77, while Jones Trading set a new target at $85. These adjustments reflect a positive outlook for Crinetics in the biotech sector, potentially attracting more investors.
Why World Pulse Now
Global Coverage
All major sources, one page
Emotional Lens
Feel the mood behind headlines
Trending Stories
Know what’s trending, globally
Read Less, Know More
Get summaries. Save time
Multi-Language
Switch languages to read your way
Save for Later
Your stories, stored for later
Live Stats
Our system has analyzed 4,210 articles worldwide
~175 per hour
581 trending stories shaping headlines
From breaking news to viral moments
Monitoring 198 trusted sources
Major outlets & specialized publications
Latest update an hour ago
Always fresh